X-154380886-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_000117.3(EMD):c.454C>T(p.Arg152Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000038 in 1,210,546 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 16 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000117.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000711 AC: 8AN: 112496Hom.: 0 Cov.: 23 AF XY: 0.000116 AC XY: 4AN XY: 34628
GnomAD3 exomes AF: 0.0000601 AC: 11AN: 183082Hom.: 0 AF XY: 0.0000443 AC XY: 3AN XY: 67734
GnomAD4 exome AF: 0.0000346 AC: 38AN: 1098050Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 12AN XY: 363462
GnomAD4 genome AF: 0.0000711 AC: 8AN: 112496Hom.: 0 Cov.: 23 AF XY: 0.000116 AC XY: 4AN XY: 34628
ClinVar
Submissions by phenotype
not provided Uncertain:5Benign:1
- -
- -
- -
- -
- -
- -
X-linked Emery-Dreifuss muscular dystrophy Uncertain:1Benign:1
- -
- -
not specified Uncertain:1
Variant summary: EMD c.454C>T (p.Arg152Cys) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico toos predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 6e-05 in 183082 control chromosomes (gnomAD). This frequency is not higher than expected for a pathogenic variant in EMD causing Emery-Dreifuss Muscular Dystrophy (6e-05 vs 0.001), allowing no conclusion about variant significance. c.454C>T has been reported in the literature in individuals affected with cardiac myopathies, however, three publications classified the variant as VUS (example: Mook_2013, Paendonck-Zwarts_2014 and Verdonschot_2020). These reports do not provide unequivocal conclusions about association of the variant with Emery-Dreifuss Muscular Dystrophy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as VUS(n=1) and likely benign (n=2). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Emery-Dreifuss muscular dystrophy 1, X-linked Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at